650 related articles for article (PubMed ID: 3028108)
21. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
22. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
[TBL] [Abstract][Full Text] [Related]
23. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
24. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
25. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
[TBL] [Abstract][Full Text] [Related]
26. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
27. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
28. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
29. Involvement of K+ movements in the membrane signal induced by PAF-acether.
Garay R; Braquet P
Biochem Pharmacol; 1986 Aug; 35(16):2811-5. PubMed ID: 3755602
[TBL] [Abstract][Full Text] [Related]
30. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.
Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P
Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526
[TBL] [Abstract][Full Text] [Related]
31. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
Ostermann G; Lorenz A; Hofmann B; Kertscher HP
J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
[TBL] [Abstract][Full Text] [Related]
32. PAF-acether (PAF) in Ehrlich ascites tumour cells.
Marathe GK; Krishnakanta TP; D'Souza CJ
J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
[TBL] [Abstract][Full Text] [Related]
33. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
[TBL] [Abstract][Full Text] [Related]
34. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of PAF-induced platelet aggregation in man.
Küster LJ; Filep J; Frölich JC
Thromb Res; 1986 Aug; 43(4):425-33. PubMed ID: 3764802
[TBL] [Abstract][Full Text] [Related]
37. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
38. Effects of PAF-acether on electrophysiological response of isolated retina.
Doly M; Braquet P; Bonhomme B; Meyniel G
Int J Tissue React; 1987; 9(1):33-7. PubMed ID: 3596955
[TBL] [Abstract][Full Text] [Related]
39. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P
Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]